Beranda › Kanker Payudara › New Jersey

Uji klinis Kanker Payudara di New Jersey

93 studi untuk Kanker Payudara mencari peserta di lokasi di New Jersey.

Kota di New Jersey

Teks studi resmi (Bahasa Inggris)

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

MD Anderson Cancer Center At Cooper, Camden
Summit Health, Florham Park
The Valley Hospital, Ridgewood

Menerima pesertaFase 3

Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05827081

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05534438

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Englewood Hospital and Medical Center, Englewood
Hackettstown Medical Center, Hackettstown
Morristown Medical Center, Morristown
dan 6 lainnya

Menerima pesertaStudi observasionalSukarelawan sehat diterima

Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

Astera Cancer Care (Formerly Regional Cancer Care Associates), East Brunswick
Medical Oncology Hematology Associates, Newark

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07102381

A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer

Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
Memorial Sloan Kettering Monmouth (Consent Only), Middletown
Memorial Sloan Kettering Bergen (Consent Only), Montvale

Menerima peserta

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07218250

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, New Brunswick

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05877599

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001), Hackensack
Rutgers Cancer Institute of New Jersey ( Site 0033), New Brunswick

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07060807

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Cooper Hospital Univ Med Ctr, MD Anderson at Cooper Voorhees, Voorhees Township

Menerima peserta

Usia 30 ke atas · Wanita · Diperbarui 25 Sep 2026 · NCT02945579

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Hackensack Univ Medical Center (HUMC) ( Site 0007), Hackensack
Rutgers Cancer Institute of New Jersey ( Site 0076), New Brunswick

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06966700

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Englewood Hospital, Englewood
Capital Health Medical Center - Hopewell, Pennington
Penn Medicine - Princeton Health, Plainsboro

Menerima pesertaFase 3

Usia 60 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06377852

A Study of Language Interpretation Solutions for People With Breast Cancer

Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge
Memorial Sloan Kettering Monmouth (Consent Only), Middletown
Memorial Sloan Kettering Bergen (Consent Only), Montvale

Menerima peserta

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06721065

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

Menerima pesertaFase 1

Usia 18 ke atas · Wanita · Diperbarui 24 Sep 2026 · NCT05412225

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06618287

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Cooper Health, Camden
Rutgers, New Brunswick

Menerima peserta

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07214532

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Jefferson Health - Cherry Hill, Cherry Hill
Sidney Kimmel Cancer Center - Washington Township, Sewell
Atlantic Health System Overlook Medical Center, Summit

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07174336

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

Memorial Sloan Kettering Basking Ridge, Basking Ridge
Memorial Sloan Kettering Monmouth, Middletown
Memorial Sloan Kettering Bergen, Montvale

Menerima pesertaFase 2

Usia 45 ke atas · Wanita · Diperbarui 21 Sep 2026 · NCT04084730

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Summit Medical Group PA, Florham Park
Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Livingston
Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Long Branch
dan 4 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07173751

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Memorial Sloan Kettering Cancer Center Basking Ridge, Basking Ridge
Summit Medical Group, Florham Park
Memorial Sloan Kettering Cancer Center Monmouth, Middletown
dan 1 lainnya

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06827236

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

MD Anderson Cancer Center at Cooper, Camden
Summit Medical Group, Florham Park
John Theurer Ctr-Hackensack UMC, Hackensack
dan 1 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06492616

A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer

Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06246968

A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery

Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale

Menerima pesertaFase 1/2

Usia 18 ke atas · Wanita · Diperbarui 11 Sep 2026 · NCT05130801

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

START - New Jersey, East Brunswick

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06293898

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Rutgers Cancer Institute, New Brunswick

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06253871

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
Hackensack Meridian Health, Hackensack
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
dan 1 lainnya

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT05570253

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

Rutgers Cancer Institute of New Jersey, New Brunswick

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07100106

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

Astera Cancer Care East Brunswick, East Brunswick

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07368998

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Rutgers Cancer Institute, New Brunswick

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06982521

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

Summit Medical Group, Florham Park

Menerima pesertaStudi observasional

Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07211178

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Astera Cancer Care East Brunswick, East Brunswick
Summit Medical Group, Florham Park

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06790693

Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale

Menerima pesertaStudi observasional

Usia 18 ke atas · Wanita · Diperbarui 3 Sep 2026 · NCT05590949

A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07287995

Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer

Cooper Hospital University Medical Center, Voorhees Township

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07076485

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale

Menerima peserta

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05837767

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Cooper Hospital University Medical Center, Camden
Jefferson Cherry Hill Hospital, Cherry Hill
Trinitas Hospital and Comprehensive Cancer Center - Williamson Street Campus, Elizabeth
dan 21 lainnya

Menerima pesertaFase 3

Usia 18 hingga 60 · Wanita · Diperbarui 2 Sep 2026 · NCT05879926

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Hunterdon Medical Center, Flemington

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06072612

Study of Aerobic Training for People Receiving Treatment for Breast Cancer

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale

Menerima pesertaFase 2

Usia 18 ke atas · Wanita · Diperbarui 27 Agu 2026 · NCT05716893

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

START New Jersey, LLC, East Brunswick

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07383506

KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer

Rutgers Cancer Institute, New Brunswick
RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05483491

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT06774963

HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
Memorial Sloan Kettering at Monmouth (Limited Protocol Activities), Middletown
Memorial Sloan Kettering at Bergen (Limited Protocol Activities), Montvale

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07459673

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.